Sam Altman-Backed Retro Bio Chases $5 Billion in AI Longevity Push
The OpenAI CEO is backing a quiet startup that wants to use AI and cell reprogramming to add 10 healthy years to human life, even though it has no clinical data yet. Retro Bio, the longevity startup backed by OpenAI CEO Sam Altman, is racing toward a 5 billion dollar valuation even though it hasn’t … Read more